Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor family, X-linked 2 (HSFX2) is a protein-coding gene located on the X chromosome and encodes a predicted DNA-binding transcription factor implicated in the regulation of transcription by RNA polymerase II. HSFX2 is primarily characterized by nuclear localization and is involved in sequence-specific DNA binding, playing a role in gene regulation but is not currently considered a direct therapeutic target. It has rare clinical associations, most notably with Partington syndrome and hypogonadotropic hypogonadism, but is not known to be strongly linked to major common diseases or to interact with approved drugs. Its closest known paralog is HSFX1, with which it shares structural features and evolutionary relationships
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock transcription factor family, X-linked 2 (HSFX2).